Weekly Policy Update: Take Action! Join a New Letter Urging Congress to Prioritize Repeal of the Medical Device Tax

Monday, August 19, 2019


Securisyn Medical Partners with Leading Medical Device Design and Development Firm, Meddux

Monday, August 12, 2019

HIGHLANDS RANCH, Colo., August 12, 2019 — Securisyn Medical, LLC, dedicated to inspiring the world to collaborate to make airway management safer, has announced a new partnership with Meddux™ Development Corp. to support the development of the Securisyn’s new product pipeline, including recent and ongoing contract awards through the U.S. Air Force (USAF) Small Business Innovation Research (SBIR) program. Meddux is a Colorado-based premier engineering design and development firm for complex medical devices, life sciences, and consumer healthcare products.  

Allosource Celebrates 25 Years Of Doing More With Life

Monday, August 12, 2019

Milestone highlights organization’s growth into one of the largest tissue banks in the U.S.  
Continue Reading

Weekly Policy Update: End the Device Tax

Friday, August 09, 2019


Weekly Policy Update: HHS and FDA Announce Plan to Allow Importation of Prescription Drugs

Friday, August 02, 2019


Zoetis Establishes Research Lab At CSU To Explore Immunotherapies For Livestock

Tuesday, July 30, 2019

Zoetis, the world’s leading animal health company, has signed an agreement with Colorado State University to establish a research lab at CSU that will explore the livestock immune system and target new immunotherapies – paving the way for new alternatives to antibiotics in food-producing animals. The new 3,000-square-foot Zoetis Incubator Research Lab will operate at the Research Innovation Center on CSU’s Foothills Campus starting in early 2020.

Read the full story at the Colorado State University's Source.

Continue Reading

Weekly Policy Update: Senate Finance Committee Advances Drug Pricing Package

Friday, July 26, 2019

On Thursday, the Senate Finance Committee advanced a major legislative package that includes substantial changes to Medicare and Medicaid drug reimbursement. The bill, the Prescription Drug Pricing Reduction Act, passed the Committee by a vote of 19-9 and will be considered by the full Senate in the fall. 

Agilent Announces Purchase of Boulder Facility

Thursday, July 25, 2019

Agilent Technologies has announced it is purchasing the building in Boulder where they have been manufacturing therapeutic oligonucleotides (“oligos") for over a decade. This $12 million purchase, along with their recent $150 million investment in their second oligo manufacturing site in Frederick, Colorado, more than doubles their capacity to produce oligos and reaffirms Agilent’s confidence in the therapeutic oligo market. Furthermore, it solidifies their commitment to doing business in the state of Colorado and their commitment to be a good corporate citizen in local communities.  

2019 Rocky Mountain Life Science Investor and Partnering Conference Announces Presenting Companies

Wednesday, July 24, 2019

September conference led by Colorado BioScience Association to provide companies from across the region new opportunities for capital access 
Continue Reading

Weekly Policy Update: We Work For Health Summit—CBSA Urges Federal Lawmakers to Promote Medical Innovation and Protect Patient Access

Monday, July 22, 2019